Fresenius SE & Co. KGaA products

Advanced design for low-flux dialysis. The removal of uremic toxins and excessive water is the fundamental goal of the hemodialysis treatment. Due to the beneficial properties of the Helixone low-flux membrane combined with its advanced product design, the FX low-flux dialyzers offer adequate performance.

High-flux dialyzer for paediatric treatments.  The FX paed dialyzer enables high-flux hemodialysis therapy ideally suited for the special needs of pediatric patients. It features the original Helixone^® membrane, which targets at an efficient removal of a broad range of uremic toxins, with minimum albumin losses and high endotoxin-retaining characteristics.⁸

High-flux dialyzers for improved patient outcomes. The FX classix dialyzers, featuring the original Helixone^® membrane, target at an efficient removal of a broad range of uraemic toxins with high endotoxin retention characteristics.^5,6.  FX classix dialyzers provide high-flux hemodialysis therapy to improve clinical outcomes in patients in comparison to low-flux hemodialysis.⁷

FX CorALs Helixone hydro membrane forms a hydrolayer on the inner membrane surface for reduced protein adsorption, resulting in a membrane with low immune response and high selective permeability. 26`27>28-29 Focal points of FX CorAL`s development were clinical performance and hemocompatibility, because these two factors belong together in patient centred dialysis.

More care. Less complexity. With the 6008 CAREsystem*, Fresenius Medical Care leverages leading-edge technology to deliver advanced dialysis therapy more easily - leaving more time for direct patient care. More patients can benefit from improved outcomes and a higher level of care quality.